Immunome (IMNM) Prepaid Assets (2019 - 2026)
Immunome's (IMNM) quarterly Prepaid Assets came in at $11.6 million in Q1 2026, up 100.03% YoY from $5.8 million in Q1 2025, and up 59.23% on a QoQ basis from $7.3 million in Q4 2025.
Immunome (IMNM) Prepaid Assets (2019 - 2026) Analysis & Trends
Immunome (IMNM) has 8 years of Prepaid Assets data on file, last reported at $11.6 million in Q1 2026.
- Quarterly Prepaid Assets rose 100.03% year-over-year to $11.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.6 million (up 100.03% YoY) and the FY2025 annual result came in at $7.3 million, up 80.75% from the prior year.
- Prepaid Assets rose to $11.6 million in Q1 2026, from $7.3 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $11.6 million in Q1 2026 to a low of $148000.0 in Q3 2023.
- A 5-year average of $4.5 million and a median of $3.9 million in 2024 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2023 — Prepaid Assets tumbled 93.15% — and 2024, when it jumped 2541.89%.
- Tracing IMNM's Prepaid Assets over 5 years: stood at $2.3 million in 2022, then surged by 182.07% to $6.6 million in 2023, then slumped by 38.48% to $4.0 million in 2024, then surged by 80.75% to $7.3 million in 2025, then surged by 59.23% to $11.6 million in 2026.
- The last three Prepaid Assets figures came in at $11.6 million (Q1 2026), $7.3 million (Q4 2025), and $7.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Immunome | 3.09 Bn | 2.57 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 18.45 Mn |
| Mar 31, 2026 | 11.62 Mn |
| Dec 31, 2025 | 7.30 Mn |
| Sep 30, 2025 | 7.29 Mn |
| Jun 30, 2025 | 9.40 Mn |
| Mar 31, 2025 | 5.81 Mn |
| Dec 31, 2024 | 4.04 Mn |
| Sep 30, 2024 | 3.91 Mn |
| Jun 30, 2024 | 5.93 Mn |
| Mar 31, 2024 | 3.62 Mn |
| Dec 31, 2023 | 6.56 Mn |
| Sep 30, 2023 | 148,000.00 |
| Jun 30, 2023 | 271,000.00 |
| Mar 31, 2023 | 2.11 Mn |
| Dec 31, 2022 | 2.33 Mn |
| Sep 30, 2022 | 2.16 Mn |
| Jun 30, 2022 | 2.95 Mn |
| Mar 31, 2022 | 1.42 Mn |
| Dec 31, 2021 | 2.02 Mn |
| Sep 30, 2021 | 4.95 Mn |